+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Endometriosis Drugs Market - Global Forecast 2025-2030- Product Image
Endometriosis Drugs Market - Global Forecast 2025-2030- Product Image
Sale

Endometriosis Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015277
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Endometriosis Drugs Market is evolving, supported by recent advances in therapeutics, delivery systems, and digital health, creating new options for patients and stakeholders. Senior decision-makers are navigating a landscape shaped by innovation, clinical demand, and adaptive supply strategies.

Market Snapshot: Endometriosis Drugs Market Outlook

The Endometriosis Drugs Market grew from USD 2.69 billion in 2024 to USD 2.89 billion in 2025. It is expected to continue growing at a CAGR of 7.29%, reaching USD 4.11 billion by 2030. This sustained momentum underscores the sector’s ability to harness clinical breakthroughs and evolve in response to emerging patient demands and shifting regulatory frameworks.

Scope & Segmentation

  • Drug Classes: Aromatase inhibitors, GnRH analogs (long-acting, short-acting), NSAIDs, oral contraceptives (biphasic, monophasic, triphasic), and progestins.
  • Distribution Channels: Hospital pharmacies (private and public), online pharmacies (direct-to-consumer, platform-based), and retail pharmacies (chain, independent).
  • Product Types: Branded and generic options available, supporting both clinical familiarity and cost containment.
  • Routes of Administration: Injectable, oral, and topical regimens designed for diverse preferences and lifestyles.
  • End Users: Clinics, home healthcare, and hospital settings, each requiring unique logistical considerations.
  • Mechanisms of Action: Hormonal therapy and pain management approaches serve different clinical and patient needs.
  • Geographic Regions: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (major and emerging countries), and Asia-Pacific (including China, India, Japan, Australia, and key Southeast Asian markets).
  • Leading Companies: AbbVie Inc., Myovant Sciences GmbH, Pfizer Inc., Bayer AG, Ferring Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc., Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories Limited.

Key Takeaways for Senior Decision Makers

  • Growing demand for personalized endometriosis therapeutics is driving innovation in hormonal modulators and pain management agents.
  • Pharmaceutical development increasingly integrates sustained-release formulations, combination regimens, and collaboration with digital health platforms to optimize outcomes.
  • Regional differences in regulation and payer systems shape drug accessibility, requiring adaptive market access and manufacturing strategies.
  • Partnering with patient advocacy groups and leveraging real-world evidence programs strengthen product positioning and patient adherence initiatives.
  • Healthcare digitalization, including telemedicine and analytics, supports remote monitoring, enhances patient experiences, and informs market planning.
  • Industry-wide collaborations and competitive entry from generic manufacturers are redefining pricing strategies and expanding access.

Tariff Impact: Shaping Strategic Supply Chains and Pricing

The introduction of new United States tariffs on pharmaceutical imports in 2025 has significantly affected procurement costs for active ingredients and specialized technologies. Manufacturers are diversifying sourcing strategies through local partnerships and logistical solutions to manage higher expenses. Comprehensive operational planning now incorporates budget recalibrations, consolidated production runs, and integrated payer analyses to safeguard market continuity and patient access. These measures help stakeholders adapt to evolving policy environments while maintaining supply chain resilience in the endometriosis drugs market.

Methodology & Data Sources

This assessment leverages a triangulated research methodology, blending expert interviews and primary insights from gynecologists, endocrinologists, pharmacoeconomists, and supply chain specialists. Secondary data were validated across peer-reviewed literature, regulatory documents, clinical trial databases, and market intelligence platforms. Quantitative and qualitative findings were benchmarked for consistency, and emerging trends were identified through real-time syntheses of market sentiment and strategic disclosures.

Why This Report Matters

  • Enables evidence-based planning with clear segmentation of drug classes, channels, and regional nuances.
  • Supports operational and commercial decisions by highlighting the impact of regulatory actions, emerging therapies, and supply chain shifts.
  • Equips organizations to identify collaboration opportunities and optimize strategies for sustainable portfolio growth and patient access.

Conclusion

By detailing market dynamics, competitive landscapes, and key drivers, this report delivers actionable insights for decision-makers seeking to navigate the evolving endometriosis therapeutics market. Stakeholders can leverage these findings to inform strategy, enhance partnerships, and address evolving care needs.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Regulatory review progress of linzagolix for endometriosis across US and EU markets
5.2. Long-term safety and bone density data emerging for oral GnRH antagonist therapies
5.3. Advancements in non-hormonal small molecule inhibitors targeting inflammatory mediators
5.4. Expansion of digital health platforms integrating remote monitoring for patient symptom tracking
5.5. Partnerships between major pharma and biotech firms accelerating neuropathic pain modulators development
5.6. Increasing off-label use of selective progesterone receptor modulators for pain management in practice
5.7. Market impact of generic elagolix introductions on pricing dynamics and access to therapy
5.8. Real-world evidence demonstrating quality-of-life improvements with novel endometriosis treatments
5.9. Emerging pipeline of long-acting subcutaneous implants for sustained estrogen suppression
5.10. Personalized medicine approaches leveraging biomarkers for targeted endometriosis drug selection
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Endometriosis Drugs Market, by Drug Class
8.1. Introduction
8.2. Aromatase Inhibitors
8.3. GnRH Analogs
8.3.1. Long-Acting
8.3.2. Short-Acting
8.4. NSAIDs
8.5. Oral Contraceptives
8.5.1. Biphasic
8.5.2. Monophasic
8.5.3. Triphasic
8.6. Progestins
9. Endometriosis Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.2.1. Private Hospital Pharmacies
9.2.2. Public Hospital Pharmacies
9.3. Online Pharmacies
9.3.1. Direct-To-Consumer Online Pharmacies
9.3.2. Platform-Based Online Pharmacies
9.4. Retail Pharmacies
9.4.1. Chain Retail Pharmacies
9.4.2. Independent Retail Pharmacies
10. Endometriosis Drugs Market, by Product Type
10.1. Introduction
10.2. Branded
10.3. Generic
11. Endometriosis Drugs Market, by Route Of Administration
11.1. Introduction
11.2. Injectable
11.3. Oral
11.4. Topical
12. Endometriosis Drugs Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Healthcare
12.4. Hospitals
13. Endometriosis Drugs Market, by Mechanism Of Action
13.1. Introduction
13.2. Hormonal Therapy
13.3. Pain Management
14. Americas Endometriosis Drugs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Endometriosis Drugs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Endometriosis Drugs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. Myovant Sciences GmbH
17.3.3. Pfizer Inc.
17.3.4. Bayer AG
17.3.5. Ferring Pharmaceuticals Inc.
17.3.6. Teva Pharmaceutical Industries Ltd.
17.3.7. Sandoz International GmbH
17.3.8. Viatris Inc.
17.3.9. Sun Pharmaceutical Industries Limited
17.3.10. Dr. Reddy’s Laboratories Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ENDOMETRIOSIS DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ENDOMETRIOSIS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ENDOMETRIOSIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ENDOMETRIOSIS DRUGS MARKET: RESEARCHAI
FIGURE 28. ENDOMETRIOSIS DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 29. ENDOMETRIOSIS DRUGS MARKET: RESEARCHCONTACTS
FIGURE 30. ENDOMETRIOSIS DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ENDOMETRIOSIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY AROMATASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY AROMATASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY LONG-ACTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY NSAIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY NSAIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY BIPHASIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY BIPHASIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MONOPHASIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MONOPHASIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY TRIPHASIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY TRIPHASIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PROGESTINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PROGESTINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DIRECT-TO-CONSUMER ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DIRECT-TO-CONSUMER ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PLATFORM-BASED ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PLATFORM-BASED ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY CHAIN RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY CHAIN RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY INDEPENDENT RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY INDEPENDENT RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 137. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 138. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 139. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 140. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 141. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 142. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 143. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 148. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 149. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 150. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 151. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 158. CANADA ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 271. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 274. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 280. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 281. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 282. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 292. GERMANY ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 293. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 294. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 295. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 296. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 297. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 298. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 299. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 302. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 303. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 304. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 305. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 306. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 307. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 314. FRANCE ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MIL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Endometriosis Drugs market report include:
  • AbbVie Inc.
  • Myovant Sciences GmbH
  • Pfizer Inc.
  • Bayer AG
  • Ferring Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Sun Pharmaceutical Industries Limited
  • Dr. Reddy’s Laboratories Limited

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.89 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.11 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Endometriosis Treatment Market - Global Forecast 2025-2030 - Product Image

Endometriosis Treatment Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Endometriosis Market Report and Forecast 2025-2034 - Product Image

Endometriosis Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Endometriosis Market Report 2025 - Product Image

Endometriosis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Endometriosis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Endometriosis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 135 Pages
  • Global
From

About the Endometriosis Drug Market

The Endometriosis Drug market is a subset of the Immune Disorders Drugs market. Endometriosis is a condition in which the tissue that normally lines the uterus grows outside of the uterus, causing pain and other symptoms. Endometriosis drugs are used to treat the symptoms of endometriosis, such as pain, heavy menstrual bleeding, and infertility. These drugs can be divided into two categories: hormonal therapies and non-hormonal therapies. Hormonal therapies include oral contraceptives, progestins, and gonadotropin-releasing hormone agonists. Non-hormonal therapies include non-steroidal anti-inflammatory drugs, danazol, and GnRH antagonists. Some companies in the Endometriosis Drug market include AbbVie, Allergan, Bayer, Merck, and Pfizer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.